| __timestamp | MiMedx Group, Inc. | PTC Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 12665000 | 79838000 |
| Thursday, January 1, 2015 | 20202000 | 121816000 |
| Friday, January 1, 2016 | 32407000 | 117633000 |
| Sunday, January 1, 2017 | 35219000 | 4577000 |
| Monday, January 1, 2018 | 36386000 | 12670000 |
| Tuesday, January 1, 2019 | 43081000 | 12135000 |
| Wednesday, January 1, 2020 | 39330000 | 18942000 |
| Friday, January 1, 2021 | 43283000 | 32328000 |
| Saturday, January 1, 2022 | 48316000 | 44678000 |
| Sunday, January 1, 2023 | 54634000 | 65486000 |
Infusing magic into the data realm
In the ever-evolving landscape of biotechnology, understanding the cost of revenue is crucial for assessing a company's financial health. This analysis delves into the cost of revenue trends for PTC Therapeutics, Inc. and MiMedx Group, Inc. from 2014 to 2023.
Over the past decade, MiMedx Group, Inc. has seen a steady increase in its cost of revenue, growing by approximately 331% from 2014 to 2023. In contrast, PTC Therapeutics, Inc. experienced a more volatile trajectory, with a significant peak in 2015, where costs surged by over 50% compared to the previous year. However, by 2023, PTC's cost of revenue had stabilized, showing a 17% increase from 2014.
These trends highlight the dynamic nature of the biotech industry, where strategic investments and market conditions can significantly impact financial outcomes.
Cost of Revenue Trends: Pfizer Inc. vs PTC Therapeutics, Inc.
Cost of Revenue: Key Insights for Zoetis Inc. and PTC Therapeutics, Inc.
Cost of Revenue Trends: United Therapeutics Corporation vs PTC Therapeutics, Inc.
Viatris Inc. vs MiMedx Group, Inc.: Efficiency in Cost of Revenue Explored
Comparing Cost of Revenue Efficiency: BioMarin Pharmaceutical Inc. vs MiMedx Group, Inc.
Cost of Revenue: Key Insights for Halozyme Therapeutics, Inc. and PTC Therapeutics, Inc.
Comparing Cost of Revenue Efficiency: Halozyme Therapeutics, Inc. vs MiMedx Group, Inc.
Analyzing Cost of Revenue: Pharming Group N.V. and MiMedx Group, Inc.
Cost of Revenue Comparison: Cytokinetics, Incorporated vs MiMedx Group, Inc.
Cost Insights: Breaking Down PTC Therapeutics, Inc. and Perrigo Company plc's Expenses
PTC Therapeutics, Inc. vs HUTCHMED (China) Limited: Efficiency in Cost of Revenue Explored
Cost of Revenue: Key Insights for PTC Therapeutics, Inc. and Dyne Therapeutics, Inc.